Current role
Biotechnology · Healthcare
Board Member, CEO
2024-11-01–present
Arun Swaminathan
Board Member
Coya Therapeutics, Inc. (COYA)Equibles does not estimate personal net worth.
Get an email with a short summary when Coya Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get COYA alertsAbout Arun Swaminathan
Arun Swaminathan is recorded as CEO at Coya Therapeutics, Inc. (COYA) since November 1, 2024 and Board Member at Coya Therapeutics, Inc. (COYA). The newest filing on record that lists Arun Swaminathan as Board Member and CEO at Coya Therapeutics, Inc. (COYA) is dated May 13, 2026. Coya Therapeutics, Inc. reported in an 8-K filed August 19, 2024 that Arun Swaminathan was appointed Class III director, effective August 19, 2024. Coya Therapeutics, Inc. reported in an 8-K filed August 19, 2024 that Arun Swaminathan was appointed Chief Executive Officer, effective November 1, 2024. The proxy statement of Coya Therapeutics, Inc. reports total compensation of $2,091,007 for Arun Swaminathan in fiscal 2025, including a base salary of $546,000. Disclosed compensation is on record for 3 fiscal years. Coya Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Coya Therapeutics, Inc. includes Dr. Arun Swaminathan (CEO), Howard Berman (Chairman), David Snyder (CFO and Board Member) and 7 others.
“On August 19, 2024, upon recommendation of the Company's Nominating and Corporate Governance Committee, Dr. Swaminathan was also appointed to the Company's Board as a Class III director to serve until the Company's 2025 annual meeting of stockholders and until his successor is duly elected and qualified.”
“Effective November 1, 2024, Arun Swaminathan, the Company's Chief Business Officer since April 2023, will serve as Chief Executive Officer of the Company.”
Affiliation history
-
Current
2024-11-01–present
Last confirmed May 13, 2026
-
Current
Start not stated–present
Last confirmed May 13, 2026
Company network
Leadership on record at Coya Therapeutics, Inc.
- Dr. Arun Swaminathan CEO
- Howard Berman Chairman
- David Snyder CFO, Board Member
- Anabella Villalobos Board Member
- Anabella Villalobos, Ph.D. Board Member
- Ann Lee Board Member
- Dieter Weinand Board Member
- Dov Goldstein Board Member
- Dov Goldstein, M.D., M.B.A. Board Member
- Fred Grossman Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Coya Therapeutics, Inc. (COYA) | Chief Executive Officer, Director | $546,000 | $2,091,007 |
| 2024 | Coya Therapeutics, Inc. (COYA) | Chief Executive Officer, Director | $441,667 | $1,497,168 |
| 2023 | Coya Therapeutics, Inc. (COYA) | Chief Executive Officer, Director | — | — |